Furthermore, CCL2, CCL3, CCL11, CCL22, CCL26 and CXCL10 were negatively associated with FXS diagnosis in a robust regression model in which we adjusted for age, BMI and time of sampling. This evidence concerns the gene CCL2 and fragile X syndrome.